You are on Trendlyne United States. Click here to go to India website or make United States as your default
person reading

About Novavax, Inc. - Company Information, Overview, History and Profile

What does Novavax, Inc. do?

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Novavax, Inc. Management structure

All Gross Remunerations are in USD
Dr. Filip Dubovsky, M.D.
President, Research and Development
-
2024
Gross Remuneration
Year
Mr. John C. Jacobs
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. James P. Kelly
Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer
-
2024
Gross Remuneration
Year

Novavax, Inc. Board of directors

All Gross Remunerations are in USD
Ms. Margaret G. McGlynn
Chairman of the Board
-
2025
Gross Remuneration
Year
Dr. James F. Young, PhD
Chairman of the Board
-
2025
Gross Remuneration
Year
Dr. John W. Shiver, PhD
Independent Director
-
2025
Gross Remuneration
Year